Atlasi Rasha, Tabatabaei-Malazy Ozra, Bandarian Fatemeh, Rezaei Nafiseh, Khashayar Pouria, Larijani Bagher
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Int J Endocrinol Metab. 2022 Aug 15;20(3):e120812. doi: 10.5812/ijem-120812. eCollection 2022 Jul.
Due to the worldwide spread of COVID-19, various countries have designed scientific studies on different aspects of the disease. Patients with diabetes mellitus (DM) have been proven to be at higher risk of COVID-19-related complications, hospitalization, and death.
The aim was to conduct a scientometric analysis of scholarly outputs on diabetes and COVID-19.
Web of Science was searched for scientific publications on diabetes and COVID-19 by Middle Eastern researchers until September 14, 2021. Collected data were analyzed for document type, subject area, countries, top journals, citation number, and authors' collaboration network using VOS viewer 1.6.15 and bibliometrix R-package 4.1.1.
Overall, the characteristics of 603 documents on DM and COVID-19 were analyzed. The top three productive countries in the field were Iran, Turkey, and Saudi Arabia. The top affiliation was from Iran; "Tehran University of Medical Sciences" (n = 168), followed by "Shahid Beheshti University of Medical Sciences" (n = 82). The total citation number was 3704 times. The highest cited paper (348) was a systematic review from Iran, published in arch Acad Emerg Med. The top source was "Diabetes & Metabolic Syndrome: Clinical Research & Reviews," with 26 documents.
The current study provides an overview of the quantity and quality of published scholarly documents on the intersection of DM and COVID-19 in the region. Our findings help scientists find the existing gaps, manage the research budgets, identify active authors and scientific institutes to collaborate with, and use their experience to produce new knowledge in the future.
由于新冠病毒病（COVID-19）在全球范围内传播，各国针对该疾病的不同方面开展了科学研究。糖尿病患者已被证实患COVID-19相关并发症、住院和死亡的风险更高。
对糖尿病与COVID-19相关学术成果进行科学计量分析。
在Web of Science中检索中东研究人员截至2021年9月14日发表的关于糖尿病与COVID-19的科学出版物。使用VOS viewer 1.6.15和bibliometrix R包4.1.1对收集的数据进行文献类型、学科领域、国家、顶级期刊、被引次数和作者合作网络分析。
总体而言，分析了603篇关于糖尿病与COVID-19的文献的特征。该领域产出最多的三个国家是伊朗、土耳其和沙特阿拉伯。主要机构来自伊朗；“德黑兰医科大学”（n = 168），其次是“谢赫·贝赫什提医科大学”（n = 82）。总被引次数为3704次。被引次数最高的论文（348次）是一篇来自伊朗的系统评价，发表在《急诊医学杂志》（arch Acad Emerg Med）上。主要来源期刊是《糖尿病与代谢综合征：临床研究与评论》（Diabetes & Metabolic Syndrome: Clinical Research & Reviews），有26篇文献。
本研究概述了该地区已发表的关于糖尿病与COVID-19交叉领域学术文献的数量和质量。我们的研究结果有助于科学家发现现有差距、管理研究预算、识别可合作的活跃作者和科研机构，并利用他们的经验在未来产生新知识。
